Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

Abstract

Proteolytic processing of viral polyproteins is indispensible for the lifecycle of coronaviruses. The main protease (M^pro) of SARS-CoV is an attractive target for anti-SARS drug development as it is essential for the polyprotein processing. M^pro is initially produced as part of viral polyproteins and it is matured by autocleavage. Here, we report that, with the addition of an N-terminal extension peptide, M^pro can form a domain-swapped dimer. After complete removal of the extension peptide from the dimer, the mature M^pro self-assembles into a novel super-active octamer (AO-M^pro). The crystal structure of AO-M^pro adopts a novel fold with four domain-swapped dimers packing into four active units with nearly identical conformation to that of the previously reported M^pro active dimer, and 3D domain swapping serves as a mechanism to lock the active conformation due to entanglement of polypeptide chains. Compared with the previously well characterized form of M^pro, in equilibrium between inactive monomer and active dimer, the stable AO-M^pro exhibits much higher proteolytic activity at low concentration. As all eight active sites are bound with inhibitors, the polyvalent nature of the interaction between AO-M^pro and its polyprotein substrates with multiple cleavage sites, would make AO-M^pro functionally much more superior than the M^pro active dimer for polyprotein processing. Thus, during the initial period of SARS-CoV infection, this novel active form AO-M^pro should play a major role in cleaving polyproteins as the protein level is extremely low. The discovery of AO-M^pro provides new insights about the functional mechanism of M^pro and its maturation process.

Keywords

SARS-CoV / main protease / crystal structure / 3D domain swapping / polyprotein processing

References

[1] Adams, P.D., Grosse-Kunstleve, R.W., Hung, L.-W., Ioerger, T.R., McCoy, A.J., Moriarty, N.W., Read, R.J., Sacchettini, J.C., Sauter, N.K., and Terwilliger, T.C. (2002). PHENIX: building new software for automated crystallographic structure determination Acta Crystallogr D 58 , 1948–1954 .
[2] Anand, K., Palm, G.J., Mesters, J.R., Siddell, S.G., Ziebuhr, J., and Hilgenfeld, R. (2002). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain. EMBO J 21, 3213–3224 .10.1093/emboj/cdf327
[3] Anand, K., Yang, H., Bartlam, M., Rao, Z. & Hilgenfeld, R. (2005). Coronavirus main proteinase: target for antiviral drug therapy. In: Coronaviruses with special emphasis on first insights concerning SARS, A. Schmidt, M.H. Wolff, and O.F. Weber, ed. (Switzerland, Basel; Birkhauser Verlag). pp. 173–199 .10.1007/3-7643-7339-3_9
[4] Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J.R., and Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300, 1763–1767 .10.1126/science.1085658
[5] Bartlam, M., Yang, H., and Rao, Z. (2005). Structural insights into SARS coronavirus proteins. Curr Opin Struct Biol 15, 664–672 .10.1016/j.sbi.2005.10.004
[6] Cattaruzza, S., and Perris, R. (2005). Proteoglycan control of cell movement during wound healing and cancer spreading. Matrix Biol 24, 400–417 .10.1016/j.matbio.2005.06.005
[7] Chan, H.L., Tsui, S.K., and Sung, J.J. (2003). Coronavirus in severe acute respiratory syndrome (SARS). Trends Mol Med 9, 323–325 .10.1016/S1471-4914(03)00135-7
[8] Chen, S., Chen, L., Tan, J., Chen, J., Du, L., Sun, T., Shen, J., Chen, K., Jiang, H., and Shen, X. (2005). Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. J Biol Chem 280, 164–173 .
[9] Chen, H., Wei, P., Huang, C., Tan, L., Liu, Y., and Lai, L. (2006). Only one protomer is active in the dimer of SARS 3C-like proteinase. J Biol Chem 281, 13894–13898 .10.1074/jbc.M510745200
[10] Chen, S., Hu, T., Zhang, J., Chen, J., Chen, K., Ding, J., Jiang, H., and Shen, X. (2008). Mutation of Gly11 on the dimer interface results in the complete crystallographic dimer dissociation of SARS-CoV 3CLpro: Crystal structure with molecular dynamics simulations. J Biol Chem 283, 554–564 .10.1074/jbc.M705240200
[11] Chen, S., Jonas, F., Chen, C., and Higenfiled, R. (2010). Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode. Protein Cell 1, 59–74 .10.1007/s13238-010-0011-4
[12] Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. (1995). NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277–293 .10.1007/BF00197809
[13] Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126–2132 .10.1107/S0907444904019158
[14] Fan, K., Wei, P., Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J., . (2004). Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem 279, 1637–1642 .10.1074/jbc.M310875200
[15] Graziano, V., McGrath, W.J., DeGruccio, A.M., Dunn, J.J., and Mangel, W.F. (2006a). Enzymatic activity of the SARS coronavirus main proteinase dimer. FEBS Lett 580, 2577–2583 .10.1016/j.febslet.2006.04.004
[16] Graziano, V., McGrath, W.J., Yang, L., and Mangel, W.F. (2006b). SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant. Biochemistry 45, 14632–14641 .10.1021/bi061746y
[17] Gronenborn, A.M. (2009). Protein acrobatics in pairs—dimerization via domain swapping. Curr Opin Struct Biol 19, 39–49 .10.1016/j.sbi.2008.12.002
[18] Hsu, W.C., Chang, H.C., Chou, C.Y., Tsai, P.J., Lin, P.I., and Chang, G.G. (2005). Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J Biol Chem 280, 22741–22748 .10.1074/jbc.M502556200
[19] Hu, T., Zhang, Y., Li, L., Wang, K., Chen, S., Chen, J., Ding, J., Jiang, H., and Shen, X. (2009). Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology 388, 324–334 .10.1016/j.virol.2009.03.034
[20] Ivanov, D., Tsodikov, O.V., Kasanov, J., Ellenberger, T., Wagner, G., and Collins, T. (2007). Domain-swapped dimerization of the HIV-1 capsid C-terminal domain. Proc Natl Acad Sci U S A 104, 4353–4358 .10.1073/pnas.0609477104
[21] Johnson, B.A., and Blevins, R.A. (1994). NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR 4, 603–614 .10.1007/BF00404272
[22] Koradi, R., Billeter, M., and Wuthrich, K. (1996). MOLMOL: a program for display and analysis of macromolecular structures. Journal of molecular graphics 14, 51–55 , 29–32 .10.1016/0263-7855(96)00009-4
[23] Kuiken, T., Fouchier, R.A., Schutten, M., Rimmelzwaan, G.F., van Amerongen, G., van Riel, D., Laman, J.D., de Jong, T., van Doornum, G., Lim, W., . (2003). Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263–270 .10.1016/S0140-6736(03)13967-0
[24] Kuo, C.-J., Chi, Y.-H., Hsu, J.T.-A., and Liang, P.-H. (2004). Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biochem Biophys Res Commun 318, 862–867 .10.1016/j.bbrc.2004.04.098
[25] Laskowski, R., MacArthur, M., Moss, D., and Thornton, J. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26, 283–291 .10.1107/S0021889892009944
[26] Lee, T.W., Cherney, M.M., Huitema, C., Liu, J., James, K.E., Powers, J.C., Eltis, L.D., and James, M.N. (2005). Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. J Mol Biol 353, 1137–1151 .10.1016/j.jmb.2005.09.004
[27] Leng, Q., and Bentwich, Z. (2003). A novel coronavirus and SARS. N Engl J Med 349, 709.10.1056/NEJMc031427
[28] Libonati, M., Gotte, G., and Vottariello, F. (2008). A novel biological actions acquired by ribonuclease through oligomerization. Curr Pharm Biotechnol 9, 200–209 .10.2174/138920108784567308
[29] Lin, P.Y., Chou, C.Y., Chang, H.C., Hsu, W.C., and Chang, G.G. (2008). Correlation between dissociation and catalysis of SARS-CoV main protease. Arch Biochem Biophys 472, 34–42 .10.1016/j.abb.2008.01.023
[30] Liu, Y., and Eisenberg, D. (2002). 3D domain swapping: as domains continue to swap. Protein Sci 11, 1285–1299 .10.1110/ps.0201402
[31] Mammen, M., Choi, S.-K., and Whitesides, G.M. (1998). Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37, 2754–2794 .10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
[32] Marley, J., Lu, M., and Bracken, C. (2001). A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR 20, 71–75 .10.1023/A:1011254402785
[33] Matthews, B.W. (1968). Solvent content of protein crystals. J Mol Biol 33, 491–497 .10.1016/0022-2836(68)90205-2
[34] McCoy, A., Grosse-Kunstleve, R., Adams, P., Winn, M., Storoni, L., and Read, R. (2007). Phaser crystallographic software. J Appl Cryst 40, 658–674 .10.1107/S0021889807021206
[35] Minor, K.H., and Peterson, C.B. (2002). Plasminogen activator inhibitor type 1 promotes the self-association of vitronectin into complexes exhibiting altered incorporation into the extracellular matrix. J Biol Chem 277, 10337–10345 .10.1074/jbc.M109564200
[36] Murshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53, 240–255 .10.1107/S0907444996012255
[37] Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. In Macromolecular Crystallography, part A , C.W. Carter Jr., and R.M. Sweet, eds. (Academic Press), pp. 307–326 .10.1016/S0076-6879(97)76066-X
[38] Po-Huang, L. (2006). Characterization and inhibition of SARS-coronavirus main protease. Curr Top Med Chem 6, 361–176 .10.2174/156802606776287090
[39] Ruthenburg, A.J., Li, H., Patel, D.J., and Allis, C.D. (2007). Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8, 983–994 .10.1038/nrm2298
[40] Shi, J., and Song, J. (2006). The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. FEBS J 273, 1035–1045 .10.1111/j.1742-4658.2006.05130.x
[41] Shi, J., Wei, Z., and Song, J. (2004). Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors. J Biol Chem 279, 24765–24773 .10.1074/jbc.M311744200
[42] Shi, J., Sivaraman, J., and Song, J. (2008). Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease. J Virol 82, 4620–4629 .10.1128/JVI.02680-07
[43] Snijder, E.J., Bredenbeek, P.J., Dobbe, J.C., Thiel, V., Ziebuhr, J., Poon, L.L., Guan, Y., Rozanov, M., Spaan, W.J., and Gorbalenya, A.E. (2003). Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331, 991–1004 .10.1016/S0022-2836(03)00865-9
[44] Tan, J., Verschueren, K.H., Anand, K., Shen, J., Yang, M., Xu, Y., Rao, Z., Bigalke, J., Heisen, B., Mesters, J.R., . (2005). pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J Mol Biol 354, 25–40 .10.1016/j.jmb.2005.09.012
[45] Verschueren, K.H.G., Pumpor, K., Anemüller, S., Chen, S., Mesters, J.R., Hilgenfeld, R., (2008). A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chem Biol 15, 597–606 .10.1016/j.chembiol.2008.04.011
[46] Wei, P., Fan, K., Chen, H., Ma, L., Huang, C., Tan, L., Xi, D., Li, C., Liu, Y., Cao, A., . (2006). The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase. Biochem Biophys Res Commun 339, 865–872 .10.1016/j.bbrc.2005.11.102
[47] Wishart, D.S., Bigam, C.G., Yao, J., Abildgaard, F., Dyson, H.J., Oldfield, E., Markley, J.L., and Sykes, B.D. (1995). 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6, 135–140 .10.1007/BF00211777
[48] Xu, T., Ooi, A., Lee, H.C., Wilmouth, R., Liu, D.X., and Lescar, J. (2005). Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer. Acta Crystallogr Sect F Struct Biol Cryst Commun 61, 964–966 .10.1107/S1744309105033257
[49] Xue, X., Yang, H., Shen, W., Zhao, Q., Li, J., Yang, K., Chen, C., Jin, Y., Bartlam, M., and Rao, Z. (2007). Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction. J Mol Biol 366, 965–975 .10.1016/j.jmb.2006.11.073
[50] Yamasaki, M., Li, W., Johnson, D.J., and Huntington, J.A. (2008). Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455, 1255–1258 .10.1038/nature07394
[51] Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., . (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A 100, 13190–13195 .10.1073/pnas.1835675100
[52] Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., . (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 3, e324.10.1371/journal.pbio.0030324
[53] Yang, H., Bartlam, M., and Rao, Z. (2006). Drug design targeting the main protease, the Achilles' heel of coronaviruses. Curr Pharm Des 12, 4573–4590 .10.2174/138161206779010369
[54] Zhong, N., Zhang, S., Zou, P., Chen, J., Kang, X., Li, Z., Liang, C., Jin, C., and Xia, B. (2008). Without its N-finger, SARS-CoV main protease can form a novel dimer through its C-terminal domain. J Virol 82, 4227–4234 .10.1128/JVI.02612-07
[55] Zhong, N., Zhang, S., Xue, F., Kang, X., Zou, P., Chen, J., Liang, C., Rao, Z., Jin, C., Lou, Z., . (2009). C-terminal domain of SARS-CoV main protease can form a 3D domain-swapped dimer. Protein Sci 18, 839–844 .